Premium
Robotic nerve‐sparing radical hysterectomy for locally advanced cervical cancer after neoadjuvant chemotherapy
Author(s) -
Liu Zhongyu,
Li Xiuli,
Li Weiping,
Yang Yizhuo,
Tao Ye,
Yao Yuanqing
Publication year - 2015
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2015.05.017
Subject(s) - medicine , parametrium , radical hysterectomy , cervical cancer , surgery , stage (stratigraphy) , retrospective cohort study , robotic surgery , hysterectomy , chemotherapy , radical surgery , cancer , paleontology , biology
Objective To evaluate the feasibility and safety of robotic nerve‐sparing radical hysterectomy for locally advanced cervical cancer (LACC). Methods In a retrospective study, data were analyzed for patients treated for cervical cancer at a center in Beijing, China, between December 2011 and September 2013. Patients were subdivided into those with early‐stage disease (FIGO stage IA2–IB1) who were treated by robotic surgery (group 1), and those with LACC (stage IB2–IIB) who were treated by robotic surgery after neoadjuvant chemotherapy (NACT; group 2). Therapeutic outcomes and complications were compared. Results Group 1 included 32 patients and group 2 included 22 patients. Two patients in group 2 did not respond to NACT and did not undergo surgery. The operative outcomes and incidences of complications did not differ significantly between the two groups ( P > 0.05 for all). There were no differences in nodal yield, lengths of parametrium removed, or vaginal cuff length ( P > 0.05 for all). During a mean follow‐up of 26 months, no patient experienced recurrence. Conclusion Robotic nerve‐sparing radical hysterectomy was found to be feasible and safe for LACC after NACT. A larger case series with longer follow‐up data is needed to justify its widespread application.